Tuberculosis during lung cancer treatment-A case series

• Published in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy Vol. 28; no. 2; pp. 339 - 342
• Main Authors: Tamura, Atsuhisa, Ikeda, Miki, Shimada, Masahiro, Yamane, Akira
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.02.2022
• Subjects: Aged; Aged, 80 and over; Cancer therapy; Humans; Latent Tuberculosis; Latent tuberculosis infection; Lung cancer; Lung Neoplasms - drug therapy; Lung Neoplasms - epidemiology; Male; Mass Screening; Middle Aged; Retrospective Studies; Risk factor; Tuberculosis; Tuberculosis - diagnosis; Tuberculosis - epidemiology; Tuberculosis; Latent tuberculosis infection; Lung cancer; Cancer therapy; Risk factor
• ISSN: 1341-321X; 1437-7780
• DOI: 10.1016/j.jiac.2021.10.017

This study aimed to clarify the characteristics of patients with lung cancer undergoing treatment until the onset of tuberculosis. Between 2005 and 2019, patients who were admitted to Tokyo National Hospital due to tuberculosis during lung cancer treatment were examined retrospectively. There were 42 patients, and detailed medical information was obtained in 39 patients. The median age of the 39 patients were 75 years (range: 47–92 years), of which 33 were males and 36 were Japanese Baby Boomers or older. Regarding risk factors for developing tuberculosis, smoking was noted in 34 cases, oral corticosteroid use in 13, and previous tuberculosis in six. Thirty-seven patients had one risk factor and 19 had two or more risk factors, but diagnosis of latent tuberculosis infection (LTBI) was obtained in only one patients, and none had received LTBI treatment. The first-line treatment for lung cancer was resection in 13 cases, chemoradiotherapy in 6, chemotherapy in 10, radiation therapy in 3, laser therapy in 1, and best supportive care (BSC) alone in 6. At tuberculosis onset, BSC accounted for 17 cases, but other situations were considerably existed such as anticancer medication (12 cases), and observation after lung cancer treatment (10 cases). Tuberculosis occurred in various situations in elderly patients with lung cancer. It is critical to actively evaluate the risk of tuberculosis and consider LTBI screening and treatment.